NCT06645379View on ClinicalTrials.gov

Application of Platelet-rich Plasma (PRP) in Reproductive Medicine

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 17, 2024

Primary Completion Date

September 15, 2027

Study Completion Date

September 15, 2027

Conditions
Premature Ovarian InsufficiencyIntrauterine AdhesionPoor Ovarian ResponseRepeated Implantation FailureThin Endometrium
Interventions
OTHER

Platelet-Rich Plasma (PRP) Injections

Transvaginal or laparoscopic injection for ovarian diseases (Premature ovarian insufficiency and Poor ovarian response). Intrauterine perfusion or sub-endometrium injection for uterine diseases (intrauterine adhesion, thin endometrium, and repeated implantation failure)

Trial Locations (1)

322000

RECRUITING

The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu

All Listed Sponsors
lead

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

OTHER